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S u m m a r y  
Pachyonychia congenita is a distinct hereditary disorder 
of keratinization, in which dystrophy of all nails is
associated with palmoplant
and oral retinoid treatment was started in one family 
member with a number of associated hyperkeratoses.
ma and other Case report
reported.




number o f associated hyperkeratoses not previously
treatment
form of pachyonychia
Pachyonychia congenita was described by Muller in
and Wilson in 1905/ Jadassohn and Lewan- 
dowski reported in 1906 on the association with palmo- 
plantar keratoderma and other ectodermal defects.' 
Since then, the presence of associated features has been
essential for the diagnosis. Based on the 
•evalence o f the associated symptoms, several classifi-
2
cations have been proposed.4“' We recently described a 
monosymptomatic form of the disease, lacking the
anomalies of the syndrome. Both autoso­
mal dominant and autosomal recessive9 modes of
*
:ritance have been described, reflecting genetic
heterogeneity. of all nails is the main
feature o f the syndrome and usually presents within
*st months of life.
Recently five patients were reported with the onset of
characteristic nail changes during the second and 
t hird decades o f  life. The term pachyonychia congenita 
tarda was proposed to describe this subset of pachyony­
chia congenita, characterized by palmoplantar kerato­
derma, hyperhidrosis and oral leucokeratosis associated 
with the nail lesions. No other hyperkeratoses were 
found to be associated.
We have observed a second family with the late-onset 
type o f pachyonychia congenita, exhibiting remarkable
A 45-year-old man presented with a hyperkeratotic skin 
disorder localized to the nails, palms, soles, knees, lower 
legs, face and scalp. The dermatosis had started at the 
age of 44 and had progressed rapidly. Painful plantar 
keratoderma prevented him from walking.
On examination, all nails were dystrophic (Fig. 1). 
The free edges were raised by thick subungual hyperker­
atosis with angulation of the lateral borders towards the 
centre. Ail nails appeared to be affected equally. In 
addition, a diffuse, thick, warty palmoplantar kerato­
derma was present (Figs 2 and 3). Nummular hyperker­
atoses were observed at the knees, and similar lesions 
were noticed at the forehead and the scalp. The lower 
legs were covered by large brown scales, mimicking 
lamellar ichthyosis.
Family history revealed that his brother and father 
had similar, although less pronounced nail changes, 
(Fig. 4), which had started in, respectively, the third 
and fourth 
hyperkeratoses.
Histopathological examination of a biopsy taken from 
the palmar skin revealed hyperkeratosis and acanthosis, 
consistent with palmoplantar keratoderma. Mycological 
culture and microscopic examination of the subungual 
hyperkeratosis proved negative.
To remove the hyperkeratoses, topical treatment was 
given with salicylic acid 20% in petrolatum, resulting in 
a significant improvement within 3 weeks. Subsequently, 
oral retinoid treatment was started with acitretin 35 mg 
daily, to prevent new hyperkeratoses from developing. 
After 2*5 weeks of therapy, a further reduction of 
hyperkeratoses was observed (Fig. 5) and the 
dosage of acitretin was reduced to 20 mg for the next 6 
weeks, with continued improvement. Because of elevated
of age, neither had additional
H i 1 • /-*i i • j  , * t i  . t  * yy rv  u i v u a i i u j l u v u xij lx  y j x  \ j  \  v i i  \ J i  u t v a L ^ Unhenotvpic heterogeneity. Combined topical keratolytic ,. ’ , , K ~ , , ,* J * r liver enzymes, the daily dosage was further reduced to
Corres : G .P.H.Lucker, Department of Dermatology,
University Hospital Nijmegen, POB 9101, 6500 HB, Nijmegen, the
10 mg for 4 weeks and eventually stopped, resulting in a 
relapse of the hyperkeratoses. The nail changes, how­
ever, responded poorly to the retinoid therapy.
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preventing new hyperkeratoses from developing in the 5. Schönfeld PHIR. The pachyonychia congenita syndrome. Acta
late-onset type. Simple local keratolytic measures proved 
useful in reducing the hyperkeratoses. 
We conclude that both the classical and late-onset 
variant of pachyonychia congenita are characterized by
number
seems
nychia congenita tarda from pachyonychia congenita by 
the differences in age of onset. Retinoids constitute a
promising approach to the treatment of the hyperker- 10. Palier ÀS, Moore JA, Scher R. Pachyonychia congenita tarda. A
Derm Venereol (Stockh) 1980; 60: 45-9 .
6. Sivasundram A, Rajagopalan K, Sarojini T. Pachyonychia
congenita, hit J  Dermatol 1985; 24: 179-80.
7. Feinstem A, Friedman J, Schewach-Millet M. Pachyonychia 
congenita. J  Am Acad Dermatol 1988; 19: 705-11.
8. Chang A, Lucker GPH, Kerkhof PCM van de, Steijlen PM. 
Pachyonychia congenita in the absence of other syndrome
abnormalities. J  Am Acad Dermatol 1994; 30: 1017-18.
9. Haber RM, Rose TH. Autosomal recessive pachyonychia con­
genita. f  Am Acad Dermatol 1988; 19: 705-11.
atoses in both variants.
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